Target : Evaluate the usefulness of a new definition of CINbased on the creatinine clearance and the Biomarkers to identify patients presenting a high risk of mortality when CIN is occurring in patients with severe acute myocardial infarction (STEMI) (PPCI)

Trial date : 2013

Number of patients : 114 – 750 pour la Biologie

Source of funding : Private (ACTION group, Fédération française de cardiologie, Société française de cardiologie)

Centers participating : Single center (Pitié-Salpêtrière)